Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Maglie

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Hematological Oncology|September 27, 2014
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patientsPier Luigi Zinzani, Alessandro Broccoli, Beatrice Casadei, et al.
Clinical and Experimental Dermatology|December 10, 2021
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemiaRoberto Maglie, Stefano Senatore, Gioia Di Stefano, et al.
Journal of Clinical Medicine|July 27, 2022
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory DiseaseMaria Efenesia Baffa, Alberto Corrà, Roberto Maglie, et al.
Frontiers in Immunology|May 20, 2022
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?Roberto Maglie, Maria Efenesia Baffa, Francesca Montefusco, et al.
The Journal of Investigative Dermatology|July 15, 2021
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of PemphigusChristoph Hudemann, Roberto Maglie, Maria Llamazares-Prada, et al.
Experimental Dermatology|March 20, 2023
Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoidRoberto Maglie, Laura Mercurio, Martina Morelli, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 23, 2025
Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous PemphigoidSimon D Lytton, Christine Wagger, Damian Meyersburg, et al.
Journal of the American Academy of Dermatology|July 15, 2021
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancyRoberto Maglie, Filippo Ugolini, Francesco De Logu, et al.
Journal of the American Academy of Dermatology|December 12, 2018
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian centerVieri Grandi, Roberto Maglie, Emiliano Antiga, et al.
Experimental Dermatology|February 20, 2026
A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy ControlsSimone Baldi, Sara Bertorello, Francesco Cei, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Hematological Oncology|September 27, 2014
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patientsPier Luigi Zinzani, Alessandro Broccoli, Beatrice Casadei, et al.
Clinical and Experimental Dermatology|December 10, 2021
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemiaRoberto Maglie, Stefano Senatore, Gioia Di Stefano, et al.
Journal of Clinical Medicine|July 27, 2022
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory DiseaseMaria Efenesia Baffa, Alberto Corrà, Roberto Maglie, et al.
Frontiers in Immunology|May 20, 2022
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?Roberto Maglie, Maria Efenesia Baffa, Francesca Montefusco, et al.
The Journal of Investigative Dermatology|July 15, 2021
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of PemphigusChristoph Hudemann, Roberto Maglie, Maria Llamazares-Prada, et al.
Experimental Dermatology|March 20, 2023
Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoidRoberto Maglie, Laura Mercurio, Martina Morelli, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 23, 2025
Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous PemphigoidSimon D Lytton, Christine Wagger, Damian Meyersburg, et al.
Journal of the American Academy of Dermatology|July 15, 2021
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancyRoberto Maglie, Filippo Ugolini, Francesco De Logu, et al.
Journal of the American Academy of Dermatology|December 12, 2018
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian centerVieri Grandi, Roberto Maglie, Emiliano Antiga, et al.
Experimental Dermatology|February 20, 2026
A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy ControlsSimone Baldi, Sara Bertorello, Francesco Cei, et al.
Pageof 9